Mitigation of pyrexia by a Th-1-biased IgG subclass response after infection with equine herpesvirus type 1 in horses pre-immunized with inactivated vaccine.

The research focuses on the immune response in horses vaccinated with an inactivated equine herpesvirus type 1 (EHV-1) vaccine and how differing IgG subclass responses may influence the onset of pyrexia (fever) post-infection. It suggests that a Th-1-biased IgG response could potentially shield horses from developing pyrexia after EHV-1 infection.

Investigating Immunoglobulin G (IgG) Subclass Responses

• The research initially explores how IgG subclass responses vary in vaccinated horses post-EHV-1 infection, with a particular focus on horses that experienced pyrexia (fever) and those who did not.
• All study subjects were situated at the training centers of the Japan Racing Association, ensuring the same environment and care for each horse.

Distinction in IgG Subclass Responses

• Researchers noticed an interesting pattern; horses that did not develop pyrexia after getting infected by EHV-1 evoked an IgG subclass response majorly dominated by IgGa and IgGb.
• In contrast, horses that developed pyrexia post-infection showed an increased production of IgGc and IgG (T) subclasses, in addition to IgGa and IgGb. This indicates that pyrexia correlates directly with a broader range of IgG subclass responses.

Inactivated EHV-1 Vaccines and Th-2-biased Responses

• Although inactivated EHV-1 vaccines are typically considered to induce a Th-2-biased response (which typically promotes humoral immunity), the results of this study suggest that not all vaccinated horses responded uniformly.
• Some vaccinated horses showed a Th-1-biased response (which is usually related to cell-mediated immunity) which, unsurprisingly, appeared to grant them protection from developing pyrexia post-EHV-1 infection.

Conclusion and Implications

• This research underscores the importance of understanding varied responses to EHV-1 vaccination and the consequent effects on horses’ health post-infection.
• The results suggest a potential advantage in promoting a Th-1-biased immune response during vaccination, as it appears to mitigate the onset of pyrexia in horses post-infection.
• This could provide vital insights for future vaccine development to deal with the equine herpesvirus, ultimately improving equine health and endurance.